FDA Authorizes Use of AI-Powered Medical Device to Detect the Most Common Skin Cancers

Dr. Tanya Evans from CalDerm is seen performing skin cancer spot screening on a firefighter in Huntington Beach, Calif., on April 30, 2023. Sophie Li/The Epoch Times

The Food and Drug Administration (FDA) has authorized the first-of-its-kind non-invasive artificial intelligence-powered medical device to detect three of the most common skin cancers in real time.

The FDA said on Jan. 16 that it had cleared the DermaSensor Inc. device, made by the Miami-based company of the same name, to be used by physicians on patients aged 40 and over.